Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-25
    E.g., 2018-09-25


51726 items
3:38 PM, Sep 14, 2018  |  BC Extra | Company News

ACS’s Brawley disappointed in Baselga resignation

American Cancer Society Chief Medical and Scientific Officer Otis Brawley said he was disappointed that José Baselga resigned from Memorial Sloan Kettering Cancer Center after failing to disclose financial ties to industry. Baselga, who was...
10:50 AM, Sep 14, 2018  |  BC Extra | Politics & Policy

Gottlieb releases FDA's plan to combat antibiotic resistance, calls for funding

FDA Commissioner Scott Gottlieb reiterated the call for new funding mechanisms to combat antimicrobial resistance during remarks made at a Pew Charitable Trusts meeting Friday. Gottlieb also revealed FDA's 2019 strategic plan to address AMR,...
10:02 AM, Sep 14, 2018  |  BC Extra | Politics & Policy

ASCO addresses financial barriers to participation in cancer trials

The American Society of Clinical Oncology proposed four ways to lower financial barriers that impede cancer patients' ability to participate in clinical trials, including a recommendation to improve payer clinical trial coverage policies. According to a...
7:55 AM, Sep 14, 2018  |  BC Extra | Financial News

Principia jumps after $106.3M IPO

Principia Biopharma Inc. (NASDAQ:PRNB) leaped $15.65 (92%) to $32.65 on Friday, its first day of trading, after raising $106.3 million late Thursday through the sale of 6.3 million shares at $17 in an IPO underwritten...
7:34 AM, Sep 14, 2018  |  BC Extra | Financial News

Ex-Kite execs prep quick IPO for CAR T play Allogene

Cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, Cowen and Jefferies. Launched in April with...
6:39 AM, Sep 14, 2018  |  BC Extra | Financial News

Hua trades flat in Hong Kong debut

Hua Medicine Ltd. (HKSE:2552) shares ended the day unchanged at HK$8.28 in the company's first day of trading Friday. The diabetes play raised HK$867 million ($110.5 million) in an IPO through the sale of 104.8...
6:20 AM, Sep 14, 2018  |  BC Extra | Financial News

Foamix raises $70M following Phase III acne readout

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) raised $70 million through the sale of 11.7 million shares at $6 in a follow-on underwritten by BofA Merrill Lynch, Cowen, Barclays and Cantor Fitzgerald. The price is a tiny discount...
4:56 PM, Sep 13, 2018  |  BC Extra | Company News

ICER panel: hATTR treatments have low value

The Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council (CEPAC) voted unanimously in separate tallies that the long-term value for money was low for hATTR treatments from Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)...
4:55 PM, Sep 13, 2018  |  BC Extra | Company News

Management tracks: Real Endpoints, Poxel, Travecta

Reimbursement consultancy Real Endpoints LLC hired Jeff Berkowitz as CEO. He replaces Roger Longman who becomes chairman. Berkowitz was EVP at UnitedHealth Group Inc. (NYSE:UNH), where he was CEO of its Optum International business and...
3:56 PM, Sep 13, 2018  |  BC Extra | Company News

Patient groups urge CVS to reconsider ICER-restricted formulary

At least 94 patient groups and individuals signed a letter urging CVS Health Corp. (NYSE:CVS) President and CEO Larry Merlo to reconsider a new formulary that would be restricted to drugs deemed cost effective by...